PRECIGEN, INC.
For the period ended Mar 31, 2026. Filed May 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 13, 2026
PGEN$4.52-4.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets as of and
Condensed Consolidated Balance Sheets
| (Amounts in thousands, except share data) | March 31,2026 | December 31,2025 |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $7,480 | $30,234 |
| Short-term investments | 48,766 | 67,624 |
| Receivables | ||
| Trade, less allowance for credit losses of $0 as of both March 31, 2026 and December 31, 2025 | 26,403 | 3,916 |
| Other | 302 | 446 |
| Inventory | 14,725 | 9,581 |
| Prepaid expenses and other | 3,996 | 3,434 |
| Total current assets | 101,672 | 115,235 |
| Long-term investments | 489 | 2,511 |
| Property, plant and equipment, net | 13,219 | 13,758 |
| Intangible assets, net | 2,864 | 3,182 |
| Goodwill | 15,232 | 15,232 |
| Right-of-use assets | 4,369 | 4,679 |
| Other assets | 782 | 908 |
| Total assets | $138,627 | $155,505 |
Condensed Consolidated Balance Sheets
| (Amounts in thousands, except share data) | March 31,2026 | December 31,2025 |
|---|---|---|
| Liabilities and Shareholders' Equity | ||
| Current liabilities | ||
| Accounts payable | $2,589 | $11,985 |
| Accrued compensation and benefits | 4,556 | 10,199 |
| Other accrued liabilities | 12,481 | 10,993 |
| Indemnification accruals | — | 2,476 |
| Deferred revenue | 410 | 517 |
| Current portion of lease liabilities | 1,068 | 1,136 |
| Total current liabilities | 21,104 | 37,306 |
| Long-term debt | 93,519 | 93,174 |
| Lease liabilities, net of current portion | 3,663 | 3,980 |
| Other long-term liabilities | 106 | 134 |
| Total liabilities | 118,392 | 134,594 |
| Commitments and contingencies (Note 14) | ||
| Shareholders' equity | ||
| Common stock, no par value, 700,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 355,903,977 shares and 353,910,926 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively. | — | — |
| Additional paid-in capital | 2,369,529 | 2,362,252 |
| Accumulated deficit | (2,349,277) | (2,341,348) |
| Accumulated other comprehensive (loss) income | (17) | 7 |
| Total shareholders' equity | 20,235 | 20,911 |
| Total liabilities and shareholders' equity | $138,627 | $155,505 |
Condensed Consolidated Statements of Operations
| (Amounts in thousands, except share and per share data) | Three Months Ended March 31, | |
|---|---|---|
| 2026 | 2025 | |
| Revenues | ||
| Product revenues, net | $21,828 | $203 |
| Service revenues | 1,424 | 1,138 |
| Total revenues | 23,252 | 1,341 |
| Operating Expenses | ||
| Cost of products and services | 2,559 | 1,100 |
| Research and development | 5,638 | 10,478 |
| Selling, general and administrative | 21,049 | 12,359 |
| Total operating expenses | 29,246 | 23,937 |
| Operating loss | (5,994) | (22,596) |
| Other Income (Expense), Net | ||
| Change in fair value of warrant liabilities | — | (32,481) |
| Interest expense | (2,908) | (1) |
| Interest income | 683 | 918 |
| Other income, net | 290 | 7 |
| Total other income (expense), net | (1,935) | (31,557) |
| Loss before income taxes | (7,929) | (54,153) |
| Income tax expense | — | — |
| Net loss | $(7,929) | $(54,153) |
| Net loss per share | ||
| Net loss per share, basic and diluted | $(0.02) | $(0.18) |
| Weighted average shares outstanding, basic and diluted | 354,291,007 | 293,879,653 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.